BayBio COO leaves after 16 months, lands in D.C.

Jeremy Leffler has quietly returned to Washington, D.C., after just 16 months as chief operating officer and CEO-to-be at the life sciences trade group BayBio.
A self-described “political junkie,” Leffler is the new director of federal policy for drug developer Sanofi-Aventis. He had spent eight years in the nation’s capital, including four as manager of federal public policy with Eli Lilly and Co., before taking the BayBio post in February 2010.